Certara Talks – Pivotal Trial Mandate
Explore how the FDA’s shift toward one pivotal trial plus supporting evidence could reshape drug…
CertaraApril 22, 2026
Certara Enters Definitive Agreement for the Sale of its Regulatory Writing and Medical Writing Business to Veristat
Transaction sharpens focus on Model-Informed Drug Development (MIDD) and Clinical Intelligence Updated 2026 guidance to…
CertaraApril 22, 2026
BaseCase® Turn Evidence into Decisions – at Scale
BaseCase value communication software transforms complex economic models and clinical data into interactive, field-ready tools.
Danielle PillsburyApril 21, 2026
FDA ESG Integration: Why Now Is the Time to Move Beyond Manual Submissions
Discover how FDA Electronic Submissions Gateway (ESG) integration reduces manual work, improves compliance, and accelerates…
CertaraApril 20, 2026
Modeling Hope: From Patient to Scientist Ellen Swanson on QSP, Breast Cancer, and Hope Through Science
Ellen Swanson, QSP Senior Scientist at Certara, shares her personal journey from breast cancer diagnosis…
CertaraApril 16, 2026
ToxStudio® Predictive Toxicology Software
Learn about ToxStudio: Predictive toxicology software to support prediction of drug-induced liver injury (DILI), QT…
CertaraApril 16, 2026
Mean Residence Time (MRT): Understanding How Long Drug Molecules Stay in the Body
JTVCdGVhbV9qdW1wX2xpc3QlNUQ= April 16, 2026 When I first began learning about pharmacokinetics (PK), I was often…
CertaraApril 16, 2026
Thieme integrates Certara Chemaxon’s new generation chemical sketcher, Marvin, into its chemical databases Science of Synthesis and Pharmaceutical Substances
Latest version of Marvin is more accurate and user-friendly for Chemical Database Subscribers Stuttgart, Germany…
Danielle PillsburyApril 14, 2026
Extending the Value of Antibody–Drug Conjugates: Model-Informed Labeling, Expansion, and Market Access
Learn how model-informed strategies support ADC labeling, dose optimization, and market access through integrated evidence…
CertaraApril 10, 2026
